title: Expression of extracellular matrix proteins in human periodontal ligament cells during mineralization in vitro.
abstract: Periodontal regeneration is a complex process that requires coordinated responses from several cell types within the periodontium. It is generally accepted that the periodontal ligament (PDL) has a heterogeneous cell population, where some of the cells may be capable of differentiating into either cementoblasts or osteoblasts. Thus, it has been hypothesized that PDL cells play a role in promoting periodontal regeneration. However, definitive evidence to support this concept is lacking. Previously, we reported that PDL cells induce biomineralization as determined by Von Kossa histochemistry and transmission electron microscopy. To further determine the osteoblast-like properties of PDL cells, human PDL cells were exposed to dexamethasone (DEX) in order to promote an osteoblast phenotype, and then cell activity monitored during mineral nodule formation in vitro. For mineralization studies, cells were cultured in DMEM containing 10% FBS and a) vehicle only; b) ascorbic acid (50 micrograms/ml) and beta-glycerophosphate (10 mM); or c) ascorbic acid, beta-glycerophosphate and DEX (100 nM) for 30 days. In addition, the effects of DEX on PDL cells in non-mineralizing media were determined. Cells were stained weekly to evaluate mineral-like nodules, using the Von Kossa method. Northern blot analyses for mRNA steady state levels for several bone-associated proteins, i.e., osteopontin (OPN), bone sialoprotein (BSP), alkaline phosphatase (ALP), osteocalcin (OCN), alpha 2(1)(type 1) collagen and osteonectin (ON), were performed. DNA levels were also determined during the 30-day mineralization period. Under phase contrast microscopy, PDL cells in non-mineralizing media treated with DEX exhibited a more spindle-shaped morphology when compared with similar cells not exposed to DEX. Mineralizing conditions were required to induce mineral nodule formation. However, in this situation, mineral induction was independent of DEX; and furthermore, DEX-treated cells did not exhibit a different morphological pattern when compared with non-DEX treated cells. Mineral-like nodules were first seen at day 15, in concert with an increase followed by a decrease in expression of type I collagen and ON mRNA in both DEX-treated and non-treated cultures. Using Northern blot analysis for detection of specific proteins, we found that PDL cells did not express OPN, BSP, OCN, or ALP under any of the conditions used in this study. DEX did not alter DNA content in the cultures during the mineralization period. These results confirm that human periodontal ligament cells can be induced to mineralize in vitro and indicate that dexamethasone does not significantly alter the extent and pattern of mineralization.
authors.affiliation: Department of Periodontics/Prevention/Geriatrics, University of Michigan, Ann Arbor, USA.
authors.forename: R M
authors.initials: RM
authors.lastname: Nohutcu
authors.forename: L K
authors.initials: LK
authors.lastname: McCauley
authors.forename: A J
authors.initials: AJ
authors.lastname: Koh
authors.forename: M J
authors.initials: MJ
authors.lastname: Somerman
mesh_terms: D000469:Alkaline Phosphatase / Q000032:analysis / Q000235:genetics; D015152:Blotting, Northern; D002113:Calcification, Physiologic / Q000187:drug effects / Q000502:physiology*; D002454:Cell Differentiation; D002478:Cells, Cultured; D003094:Collagen / Q000032:analysis / Q000235:genetics; D003470:Culture Media; D004247:DNA / Q000032:analysis / Q000235:genetics; D003739:Dental Cementum / Q000166:cytology / Q000502:physiology; D003907:Dexamethasone / Q000494:pharmacology; D016326:Extracellular Matrix Proteins / Q000032:analysis / Q000096:biosynthesis* / Q000187:drug effects / Q000235:genetics; D005786:Gene Expression Regulation; D005938:Glucocorticoids / Q000494:pharmacology; D006651:Histocytochemistry; D006801:Humans; D058574:Integrin-Binding Sialoprotein; D008854:Microscopy, Electron; D010006:Osteoblasts / Q000166:cytology / Q000502:physiology; D015675:Osteocalcin / Q000032:analysis / Q000235:genetics; D015676:Osteonectin / Q000032:analysis / Q000235:genetics; D053495:Osteopontin; D010513:Periodontal Ligament / Q000166:cytology / Q000187:drug effects / Q000378:metabolism* / Q000502:physiology; D010750:Phosphoproteins / Q000032:analysis / Q000235:genetics; D012333:RNA, Messenger / Q000032:analysis / Q000235:genetics; D012038:Regeneration; D012795:Sialoglycoproteins / Q000032:analysis / Q000235:genetics
chemical_list: D003470:Culture Media; D016326:Extracellular Matrix Proteins; D005938:Glucocorticoids; C546871:IBSP protein, human; D058574:Integrin-Binding Sialoprotein; D015676:Osteonectin; D010750:Phosphoproteins; D012333:RNA, Messenger; C506895:SPP1 protein, human; D012795:Sialoglycoproteins; D015675:Osteocalcin; D053495:Osteopontin; D003907:Dexamethasone; D003094:Collagen; D004247:DNA; D000469:Alkaline Phosphatase